Canandaigua National Corp’s West Pharmaceutical WST Stock Holding History

Canandaigua National Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$219K	Buy	929 +3	+0.3%	+$711	0.04%	235
2022 Q3	$228K	Sell	926 -2	-0.2%	-$609	0.04%	222
2022 Q2	$281K	Buy	928 +135	+17%	+$43.9K	0.05%	201
2022 Q1	$326K	Sell	793 -1,002	-56%	-$392K	0.05%	211
2021 Q4	$842K	Sell	1,795 -19	-1%	-$8.18K	0.12%	153
2021 Q3	$770K	Buy	1,814 +883	+95%	+$372K	0.13%	154
2021 Q2	$334K	Sell	931 -103	-10%	-$34K	0.05%	205
2021 Q1	$291K	Sell	1,034 -94	-8%	-$26.9K	0.05%	218
2020 Q4	$320K	Sell	1,128 -41	-4%	-$11.5K	0.06%	205
2020 Q3	$321K	Sell	1,169 -138	-11%	-$36.5K	0.06%	196
2020 Q2	$297K	Buy	+1,307	New	+$257K	0.05%	204

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return